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Introduction
CMR is increasingly used in the assessment of mitral valve
disease, especially mitral regurgitation. Although quantifi-
cation of the severity of mitral regurgitation using CMR is
well established, assessment of the mechanism of mitral
regurgitation by CMR i.e. mitral valve leaflet anatomy and
dysfunction is often suboptimal. Additional imaging
planes to the standard 2-chamber, 4-chamber and LVOT
cines are necessary in order to visualise each component
of the mitral valve leaflet (A1–A3, P1–P3) and determine
valve dysfunction such as prolapse or restriction. In addi-
tion, assessment of regional and global left ventricular
(LV) function, contractile reserve and viability is necessary
in functional mitral regurgitation, e.g. secondary to
ischemic heart disease. We describe our technique for
assessing the mitral valve using CMR and illustrate it with
case examples of degenerative, ischemic and rheumatic
mitral valve disease.
Methods
Following standard imaging sequences, including cines of
2-chamber, 4-chamber, LVOT, and a short axis stack, the
mitral valve is thoroughly imaged. A basal short axis slice
is selected which shows the mitral valve. From this, a stack
of oblique slices all parallel to the LVOT long axis plane
are taken of the mitral valve starting from the inferior
commissure and at intervals of 5 mm up to the superior
commissure. A pair of further slices are taken at each com-
missure perpendicular to the plane of coaptation of the
leaflets. From this, each component of the mitral valve
(A1–A3, P1–P3) is identified and any dysfunction
defined. We use SSFP end-expiratory breath hold cines,
retrospective ECG gating, high temporal resolution, repe-
tition time 1.86 ms, echo time 1.13 ms, in plane pixel size
1,7 × 1.7 mm, flip angle 80 degrees, acquisition time 16
heart beats, slice thickness 5 mm. Velocity mapping of
aortic flow is next performed to allow quantification of
mitral regurgitation. In patients with ischemic mitral
regurgitation, we further assess regional LV viability and
contractile reserve using low dose dobutamine stress at 5
and 10 mcg/kg/min followed by gadolinium.
Conclusion
Using this examination technique, each component of the
mitral valve (A1–A3, P1–P3) is clearly identified and any
dysfunction determined. The severity of mitral regurgita-
tion is quantified. Regional and global LV function and
viability is defined. CMR is able to provide a detailed and
comprehensive assessment of the mitral valve leaflets and
dysfunction and of LV size, function, and viability in a sin-
gle examination. When used optimally, CMR may com-
plement existing imaging modalities such as
echocardiography in the assessment of mitral valve dis-
ease.
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